S. 1173 · Senate · Introduced Mar 27, 2025

Restore Protections for Dialysis Patients Act

Sponsored by Bill Cassidy (R, LA)

INTRODUCED
COMMITTEE
Mar 27, 2025
PASSED SENATE
HOUSE
H.R. 2199, companion — in committee
LAW

In committee. Latest action on Mar 27, 2025: Read twice and referred to the Committee on Finance. Its identical companion H.R. 2199 is in committee. It has and 2 recorded actions, and cited it in Q2 2026 lobbying disclosures.

Recent actions

2 total

Mar 27, 2025 · Library of Congress

Introduced in Senate

Mar 27, 2025 · Senate

Read twice and referred to the Committee on Finance.

Reported lobbying

17

organizations cited S. 1173 in a lobbying disclosure

Q2 2026 · the most recent completed reporting period you can see

Organization	Filed by	Total Q2 2026 lobbying
Lockheed Martin	In-house	$4,180,000
Boeing	In-house	$2,770,000
Fresenius Medical Care North America	Avenue Solutions	$1,250,000
Davita	Red+blue Strategies	$1,210,000
Dialysis Patient Citizens	Kountoupes Denham Carr & Reid	$530,000

These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.

Latest activity

August 2026

Lobbying reported · Lester Health Law · Aug 10

Lester Health Law reported 2nd Quarter (Apr 1 - June 30) lobbying for U.S. Renal Care — $23,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

July 2026

Lobbying reported · Federal Street Strategies · Jul 21

Federal Street Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Davita — $60,000

BillsH.R. 2199 S. 1173

Lobbying reported · Capitol Hill Consulting Group · Jul 21

Capitol Hill Consulting Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Davita — $60,000

BillsH.R. 2199 S. 1173

Lobbying reported · Nvg · Jul 20

Nvg reported 2nd Quarter (Apr 1 - June 30) lobbying for Service Employees International Union — $80,000

BillsH.R. 2199 H.R. 9237 S. 2 S. 1173 S. 3466

Lobbying reported · Boeing · Jul 20

Boeing reported 2nd Quarter (Apr 1 - June 30) lobbying for Boeing — $2,770,000

Lobbying reported · Akebia Therapeutics · Jul 20

Akebia Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Akebia Therapeutics — $360,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

Lobbying reported · Dialysis Patient Citizens · Jul 20

Dialysis Patient Citizens reported 2nd Quarter (Apr 1 - June 30) lobbying for Dialysis Patient Citizens — $500,000

BillsH.R. 2199 H.R. 4582 H.R. 6214 S. 1173 S. 1552 S. 2730

Lobbying reported · Lockheed Martin · Jul 20

Lockheed Martin reported 2nd Quarter (Apr 1 - June 30) lobbying for Lockheed Martin — $4,180,000

BillsH.R. 2199 H.R. 4710 H.R. 8752 H.R. 8800 H.R. 8845 H.R. 9171 H.R. 9495 S. 933 S. 1173 S. 2420 S. 4615 S. 4784 S. 4802 S. 4874

Lobbying reported · American Kidney Fund · Jul 20

American Kidney Fund reported 2nd Quarter (Apr 1 - June 30) lobbying for American Kidney Fund — $240,000

BillsH.R. 1518 H.R. 2199 H.R. 4582 H.R. 4583 H.R. 5259 H.R. 6214 H.R. 6280 H.R. 7868 H.R. 8875 S. 1173 S. 1552 S. 2730 S. 2751 S. 3607

Lobbying reported · Powers Pyles Sutter & Verville, P.c. · Jul 20

Powers Pyles Sutter & Verville, P.c. reported 2nd Quarter (Apr 1 - June 30) lobbying for Davita — $20,000

BillsH.R. 6860 S. 1173

Lobbying reported · Davita · Jul 20

Davita reported 2nd Quarter (Apr 1 - June 30) lobbying for Davita — $980,000

BillsH.R. 2199 H.R. 3944 H.R. 6214 H.R. 8376 H.R. 8875 S. 1173 S. 2730

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Fresenius Medical Care North America — $60,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

Lobbying reported · American Association of Nurse Practitioners · Jul 20

American Association of Nurse Practitioners reported 2nd Quarter (Apr 1 - June 30) lobbying for American Association of Nurse Practitioners — $400,000

Lobbying reported · Federal Health Policy Strategies · Jul 20

Federal Health Policy Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Kidney Care Partners — $80,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

Lobbying reported · Jeffrey J. Kimbell & Associates · Jul 20

Jeffrey J. Kimbell & Associates reported 2nd Quarter (Apr 1 - June 30) lobbying for U.S. Renal Care — $50,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

Lobbying reported · Fresenius Medical Care North America · Jul 20

Fresenius Medical Care North America reported 2nd Quarter (Apr 1 - June 30) lobbying for Fresenius Medical Care North America — $1,190,000

BillsH.R. 2199 H.R. 4582 H.R. 4583 H.R. 6214 S. 1173 S. 1552 S. 2730

Lobbying reported · Fierce Government Relations · Jul 20

Fierce Government Relations reported 2nd Quarter (Apr 1 - June 30) lobbying for Corporate Health Care Coalition — $30,000

BillsH.R. 2199 H.R. 4710 S. 1173 S. 2420

Lobbying reported · Red+blue Strategies · Jul 17

Red+blue Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Davita — $70,000

BillsH.R. 2199 S. 1173

Lobbying reported · Mehlman Consulting · Jul 17

Mehlman Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for Renal Healthcare Association — $70,000

BillsH.R. 2199 H.R. 6214 S. 1173 S. 2730

Lobbying reported · The Ferraro Group · Jul 17

The Ferraro Group reported 2nd Quarter (Apr 1 - June 30) lobbying for The Rogosin Institute — $30,000

BillsH.R. 2199 H.R. 4582 H.R. 4583 H.R. 6214 S. 1173 S. 1552 S. 2730